Previous close | 8.13 |
Open | 8.50 |
Bid | 8.35 |
Ask | 8.75 |
Strike | 20.00 |
Expiry date | 2026-01-16 |
Day's range | 8.30 - 8.77 |
Contract range | N/A |
Volume | |
Open interest | 7.65k |
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.